CORDIOPREV Trial
The CORDIOPREV trial compared the efficacy of a Mediterranean diet against a low-fat diet in patients with coronary heart disease (CHD). The study found that the Mediterranean diet group had a 28.1% lower risk of recurrent major-adverse-cardiovascular-events (MACE).
Additional Findings
- Kidney protection: The trial showed attenuated eGFR decline, relevant to chronic-kidney-disease.
- Direct comparison: mediterranean-vs-low-fat-diet details the full dietary comparison.